Global Bare-metal Vascular Stents Market Size By Type (Coronary Stents, Peripheral Stents), By Application (Hospitals And Cardiac Centers, Ambulatory Surgical Centers), By Region, And Segment Forecast...

The Global Bare-metal Vascular Stents Market was valued at USD 1.1 billion in 2023 and is expected to surpass USD 1.68 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2023–2031). The market is driven by the rising prevalence of cardiovascular diseases, the increasing number of percutaneous coronary interventions (PCI), and the cost-effectiveness of bare-metal stents (BMS) compared to drug-eluting stents (DES). Bare-metal vascular stents continue to play a crucial role in cases where patients have a high bleeding risk or when dual antiplatelet therapy is not ideal.

Drivers:

1. Rising Cardiovascular Disease Burden

The growing global incidence of coronary artery diseases, particularly in aging populations, is a primary driver for the BMS market. Cardiovascular diseases remain the leading cause of mortality worldwide, and stenting is a key intervention.

2. High Suitability for Certain Patient Groups

Bare-metal stents are preferred for patients with high bleeding risk or those who may require non-cardiac surgery soon after stent placement. Their shorter required duration of dual antiplatelet therapy enhances their clinical utility.

3. Cost Efficiency and Accessibility

Compared to newer-generation stents, bare-metal stents are more affordable and remain a viable option in resource-constrained settings and developing economies.

Restraints:

1. Technological Shift to Drug-Eluting Stents

The rapid adoption of drug-eluting stents, known for reduced restenosis rates and longer patency, has limited the growth of the BMS segment, especially in developed markets.

2. Risk of In-stent Restenosis

One of the critical limitations of BMS is the higher likelihood of restenosis, which can lead to repeat revascularization procedures and affect long-term outcomes.

Opportunity:

1. Market Expansion in Emerging Economies

As access to healthcare improves in Asia-Pacific, Latin America, and parts of Africa, the affordability and accessibility of bare-metal stents offer significant market potential.

2. Innovation in Stent Design and Materials

Ongoing R&D efforts are focused on enhancing the performance of BMS through improved alloy compositions and thinner strut designs, potentially revitalizing demand.

Market by System Type Insights:

Based on system type, the Balloon-Expandable Bare-metal Stents segment held the largest market share in 2023. These stents offer superior radial strength and are preferred for precise placement in coronary arteries. The Self-Expanding Bare-metal Stents segment is anticipated to witness moderate growth due to its application in peripheral vascular diseases and complex anatomies.

Market by End-use Insights:

In 2023, the Hospitals segment was the dominant end-use category, accounting for over 60% of total revenue. Hospitals remain the primary centers for cardiovascular interventions globally. The Ambulatory Surgical Centers (ASCs) segment is expected to grow at a faster pace due to the shift towards outpatient procedures and the benefits of reduced cost and shorter recovery times.

Market by Regional Insights:

North America led the global bare-metal vascular stents market in 2023, fueled by a high prevalence of heart diseases, robust healthcare infrastructure, and favorable reimbursement policies. Asia-Pacific is projected to register the highest CAGR during the forecast period due to increasing healthcare spending, a rising geriatric population, and expanding access to interventional cardiology procedures in countries like India and China.

Competitive Scenario:

Prominent players in the global bare-metal vascular stents market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, and Terumo Corporation. These companies are focused on portfolio diversification, regional expansion, and continuous innovation.

In 2024, Abbott launched an advanced cobalt-chromium bare-metal stent offering improved flexibility and reduced strut thickness.

Medtronic expanded its footprint in Southeast Asia through partnerships aimed at supplying affordable vascular stents in underserved regions.

Scope of Work – Global Bare-metal Vascular Stents Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 1.68 billion

CAGR (2023–2031) 5.5%

Market Segments By System Type, End-use, Region

Growth Drivers Rising cardiovascular disease, cost-effectiveness

Opportunities Emerging markets, stent material innovation

Key Market Developments:

2023: BIOTRONIK received CE Mark for a new generation of cobalt-chromium bare-metal stents with enhanced radial strength and deliverability.

2024: Boston Scientific collaborated with a cardiovascular institute in Latin America to provide aff